Michelle Lancet

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Design, rationale, and baseline characteristics of a randomized controlled trial evaluating a mobile relational agent to enhance atrial fibrillation self-care”.

Design, rationale, and baseline characteristics of a randomized controlled trial evaluating a mobile relational agent to enhance atrial fibrillation self-care

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.107015

N/A

0.287DataRank · unranked

4 citations

Kaleab Z. Abebe, Michael K. Paasche‐Orlow, Christina M. Lalama, Danielle Ferry, Michelle Lancet +4 more

A mobile relational agent to enhance atrial fibrillation self-care: Primary and secondary outcomes of a randomized controlled trial

American Heart Journal(2025)10.1016/j.ahj.2025.06.009

N/A

0.208DataRank · unranked

3 citations

Christina M. Lalama, Kaleab Z. Abebe, Danielle Ferry, Bruce L. Rollman, Michelle Lancet +5 more

ACE trial design: Equol targeting estrogen receptor‐β in vascular and cognitive aging

Alzheimer s & Dementia Translational Research & Clinical Interventions(2025)10.1002/trc2.70144

N/A

0DataRank · unranked

5 citations

Whitney Wharton, Cristina Murray‐Krezan, Minjie Wu, Yue-Fang Chang, Beth E. Snitz +20 more